Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel (2015)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.2174/1570161113666150827125040
- Subjects: DOENÇAS GENÉTICAS; MUTAÇÃO GENÉTICA; HIPERCOLESTEROLEMIA
- Language: Inglês
- Imprenta:
- Publisher place: San Francisco
- Date published: 2015
- Source:
- Título: Current Vascular Pharmacology
- ISSN: 1570-1611
- Volume/Número/Paginação/Ano: v. 13, n. 6, p. 759-770, 2015
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
AL-ASHWAL, Abdullah et al. Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel. Current Vascular Pharmacology, v. 13, n. 6, p. 759-770, 2015Tradução . . Disponível em: https://doi.org/10.2174/1570161113666150827125040. Acesso em: 28 jan. 2026. -
APA
Al-Ashwal, A., Alnouri, F., Sabbour, H., Al-Mahfouz, A., Al-Sayed, N., Razzaghy-Azar, M., et al. (2015). Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel. Current Vascular Pharmacology, 13( 6), 759-770. doi:10.2174/1570161113666150827125040 -
NLM
Al-Ashwal A, Alnouri F, Sabbour H, Al-Mahfouz A, Al-Sayed N, Razzaghy-Azar M, Al-Allaf F, Al-Waili K, Banerjee Y, Genest J, Santos RD, Al-Rasadi K. Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel [Internet]. Current Vascular Pharmacology. 2015 ; 13( 6): 759-770.[citado 2026 jan. 28 ] Available from: https://doi.org/10.2174/1570161113666150827125040 -
Vancouver
Al-Ashwal A, Alnouri F, Sabbour H, Al-Mahfouz A, Al-Sayed N, Razzaghy-Azar M, Al-Allaf F, Al-Waili K, Banerjee Y, Genest J, Santos RD, Al-Rasadi K. Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel [Internet]. Current Vascular Pharmacology. 2015 ; 13( 6): 759-770.[citado 2026 jan. 28 ] Available from: https://doi.org/10.2174/1570161113666150827125040 - Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps
- Characterizing familial chylomicronemia syndrome: baseline data of the APPROACH study
- Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia
- Sex disparity in the management and outcomes of dyslipidemia of diabetic patients in the Arabian Gulf: findings from the CEPHEUS study
- Vertebral bone density by quantitative computed tomography mirrors bone structure histomorphometric parameters in hemodialysis patients
- Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia
- Increased subclinical atherosclerosis burden in familial hypercholesterolemia phenotype [Editorial]: What do genetic defects tell us and what are the clinical implications?
- Sodium intake and prevalence of hypertension in elementary school students
- Clinical Genetic Testing for Familial Hypercholesterolemia
- Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: results from the SPIRE randomized trials of bococizumab
Informações sobre o DOI: 10.2174/1570161113666150827125040 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
